title: [Efficacy of intravenous ceftazidime in childhood infections].
abstract: Ceftazidime, a beta-lactamase resistant cephalosporin, was administered intravenously to 33 patients with various infections. The age range was between 3 days and 15 years and substantial underlying disease was present in 90% of the patients and 72% had malignancy. Seventeen (51.5%) were in critical condition and twenty had granulocytopenia. Clinical and microbiological results were evaluated and overall clinical response was 88%. No major adverse effects were encountered. Ceftazidime was an effective and safe therapy for serious infections and neutropenic patients.
authors.affiliation: Hacettepe Universitesi, Pediatri Anabilim Dali.
authors.forename: G
authors.initials: G
authors.lastname: Kanra
authors.forename: M
authors.initials: M
authors.lastname: Gürsavaş
authors.forename: M
authors.initials: M
authors.lastname: Aydin
authors.forename: R
authors.initials: R
authors.lastname: Cengizlier
authors.forename: G
authors.initials: G
authors.lastname: Seçmeer
authors.forename: M
authors.initials: M
authors.lastname: Ceyhan
mesh_terms: D000293:Adolescent; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D002442:Ceftazidime / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007275:Injections, Intravenous; D008297:Male; D009503:Neutropenia / Q000150:complications*
chemical_list: D002442:Ceftazidime
vernacular_title: Cocukluk çaği enfeksiyonlarinda intravenöz seftazidim'in etkinliği.